Efficacy does not necessarily translate to cost effectiveness: A case study in the challenges associated with 21st-century cancer drug pricing

Bruce E. Hillner, Thomas J. Smith

Research output: Contribution to journal › Editorial › peer-review

100 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy does not necessarily translate to cost effectiveness: A case study in the challenges associated with 21st-century cancer drug pricing'. Together they form a unique fingerprint.